Aripiprazole Monohydrate is an atypical antipsychotic medication primarily indicated for the treatment of schizophrenia, bipolar I disorder, major depressive disorder, irritability associated with autism,… Read more
Aripiprazole Monohydrate is an atypical antipsychotic medication primarily indicated for the treatment of schizophrenia, bipolar I disorder, major depressive disorder, irritability associated with autism, and Tourette's disorder. It functions as a dopamine system stabilizer, acting as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, while exerting antagonist activity at serotonin 5-HT2A receptors. To support the rigorous analytical testing and quality control required for this active pharmaceutical ingredient, laboratories utilize a comprehensive range of reference standards. These include pharmacopeial and non-pharmacopeial impurities, degradation products, metabolites, and stable isotope-labelled compounds. These high-quality standards are essential for impurity profiling, method validation, and ensuring the accuracy of stability-indicating assays, allowing researchers and quality control professionals to maintain compliance with regulatory standards throughout the pharmaceutical development and manufacturing process.